Ultime notizie per Helix BioPharma (OTC:HBPCF) Azioni

Helix BioPharma Corp is a clinical-stage biopharmaceutical company. It is focused on cancer drug development. The company develops therapies in the field of immuno-oncology based on its proprietary technology mainly in the areas of cancer prevention and treatment. Its pipeline candidates are Tumor Defence Breaker L-DOS47, and, V-DOS47 among others.

HELIX BIOPHARMA CORP by Helix Biopharma Corp.

Helix BioPharma Corp

News

ICCT

iCoreConnect Expands Partnership With Arizona Dental Association To Include Five Endorsed Products, Enhancing Revenue Cycle Management And Efficiency For Dental Practices

Evercore ISI Group maintains BrightSphere Investment (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BSIG#NYSE">BSIG</a>) with a In-Line and raises the price target from $28 to $31.

Price Target

Analyst Ratings

BrightSphere Investment Group plc Ordinary Shares

BSIG

Evercore ISI Group Maintains In-Line on BrightSphere Investment, Raises Price Target to $31

WIIM

FRSH

Freshworks shares are trading higher after the company reported better-than-expected Q3 financial results.

WKHS

Workhorse Announces Multiple Recent Orders For W56 Electric Step Vans

LiveOne shares are trading lower after the company reported worse-than-expected Q2 financial results.

<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.graniteconstruction.com&amp;esheet=54147671&amp;newsitemid=20241107459362&amp;lan=en-US&amp;anchor=Granite&amp;index=1&amp;md5=dc95013cea063cae6d572aa35a9f2778">Granite </a>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GVA#NYSE">GVA</a>) announced that it has been awarded the civil scope of work for Phase 1 of the Mosaic Quarter project, an approximately $27 million subcontract for general contractor Hensel Phelps. Mosaic Quarter is a sports and entertainment-focused lifestyle center, serving as a destination point for residents and visitors. It features state-of-the-art venues for entertainment, recreational and collegiate sports, including ice hockey, basketball, soccer, and much more.
The project is situated near South Kino Parkway and I-10 in Tucson, Arizona and is being developed, funded, and operated by Mosaic Quarter Development. The award is included in Granite's fourth-quarter CAP.
This keystone project supports the City of Tucson, Pima County, and Southern Arizona and continues Granite's history of building successful projects with Hensel Phelps.

Contracts

Granite Announces Phase 1 Of The $425M Mosaic Quarter Development In Tucson, Arizona, An ~$27M Subcontract Has Been Awarded For General Contractor Hensel Phelps

ALTO

Alto Ingredients shares are trading lower after the company reported worse-than-expected Q3 financial results.

Guardant Health shares are trading higher after the company reported better-than-expected Q3 financial results and raised its FY24 revenue guidance above estimates.

Evercore ISI Group analyst Glenn Schorr maintains BlackRock (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BLK#NYSE">BLK</a>) with a Outperform and raises the price target from $1040 to $1160.

Evercore ISI Group Maintains Outperform on BlackRock, Raises Price Target to $1160

PESI

Perma-Fix Environmental Services Launches First Commercial Perma-FAS System For PFAS Destruction, Achieving 99.99% Breakdown Of PFAS Compounds At Florida Facility

MBIO

Mustang Bio Announces The FDA Has Granted Orphan Drug Designation To MB-108

The Hershey Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HSY#NYSE">HSY</a>) shares are <a target="_blank" href="https://www.benzinga.com/premarket" rel="noreferrer noopener">trading lower in the premarket session on Thursday.</a>
The company reported third-quarter adjusted earnings per share of $2.34, <a target="_blank" href="https://www.benzinga.com/pressreleases/24/11/n41801901/hershey-reports-third-quarter-2024-financial-results-updates-2024-net-sales-and-earnings-outlook" rel="noreferrer noopener">missing the street view of $2.56</a>. Quarterly sales of $2.987 billion (down 1.4%) missed the analyst consensus of $3.077 billion.
Organic net sales dropped 1.0%, as higher prices were offset by lower volume across segments and reduced inventory in North America Salty Snacks ahead of the ERP system rollout in the fourth quarter of 2023.
&#8220;While year-to-date results have been affected by historically high cocoa prices and a challenging consumer environment, we are laser-focused on controlling what we can and are acting with immediacy to deliver value to customers, consumers and shareholders,&#8221; said&nbsp;Michele Buck, Hershey President and Chief Executive Officer.
Also Read: <a target="_blank" href="https://www.benzinga.com/news/earnings/24/11/41801920/us-stocks-likely-to-open-higher-extending-post-election-rally-feds-rate-decision-on-investors-radar" rel="noreferrer noopener">US Stocks Likely To Open Higher, Extending Post-Election Rally: Fed&#8217;s Rate Decision On Investors&#8217; Radar As Expert Highlights Markets Scaling 48 All-Time Highs This Year</a>
North America Confectionery unit gained 0.8% in the quarter under review, while North America Salty Snacks fell 15.5%, and International down 3.9%.
Adjusted gross margin was 40.3% in the quarter under review, down 460 basis points from the year-ago period.
This decline was due to higher commodity costs, timing issues, fixed cost increases, and unfavorable product mix, despite price hikes and productivity gains.
Adjusted operating profit was $654.0 million, down 13.2% in the year-ago period. This led to an operating profit margin of 21.9%, a 300 basis point decrease.
The company exited the quarter with cash and equivalents worth &nbsp;$614.95 million, with net inventories worth $1.301 billion. Long-term debt as of quarter-end was $3.189 billion.
Dividend: The company announced quarterly dividends of&nbsp;$1.370&nbsp;on the common stock and&nbsp;$1.245&nbsp;on the Class B common stock. The dividends were declared&nbsp;November 6<a target="_blank" href="https://www.benzinga.com/pressreleases/24/11/n41801901/hershey-reports-third-quarter-2024-financial-results-updates-2024-net-sales-and-earnings-outlook" rel="noreferrer noopener"> and are payable&nbsp;December 16.</a>&nbsp;
Outlook: Hershey cuts FY24 adjusted earnings per share view to $9.00 &#8211; $9.10 versus $9.40 estimate (<a target="_blank" href="https://www.benzinga.com//node/40094440" rel="noreferrer noopener">from $9.49 &#8211; $9.59</a>). The company sees flat net sales in FY24, compared with the prior view of 2% growth.
Price Action: HSY shares are trading lower by 2.88% to $171.72 premarket at last check Thursday.
Image by Melissa from Pixabay
Read Next:
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/11/41798981/jim-cramer-calls-trumps-return-to-white-house-a-huge-win-for-the-stock-market" target="_blank" rel="noreferrer noopener">Jim Cramer Calls Trump's Return To White House A ‘Huge Win For The Stock Market'</a></li>
</ul>

Earnings

Equities

Large Cap

Guidance

Markets

Movers

General

Hershey's Q3 Earnings Sour As Sales Dip And Outlook Darkens; CEO Pledges Aggressive Turnaround Amid High Cocoa Costs

Evercore ISI Group analyst Mark Lipacis maintains ARM Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARM#NASDAQ">ARM</a>) with a Outperform and raises the price target from $173 to $176.

Evercore ISI Group Maintains Outperform on ARM Holdings, Raises Price Target to $176

TRIB

Trinity Biotech Regains Nasdaq Compliance With Minimum Market Value Requirement

Cousins Properties To Acquire 639,000 Sq. Ft. Vantage South End Office Property In Charlotte For $328.5M, Expanding Presence In South End Market With 97% Occupancy

Evercore ISI Group analyst John Dunn maintains Artisan Partners Asset (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/APAM#NYSE">APAM</a>) with a In-Line and raises the price target from $40 to $44.

APAM

Evercore ISI Group Maintains In-Line on Artisan Partners Asset, Raises Price Target to $44

BROS

Dutch Bros shares are trading higher after the company reported better-than-expected Q3 financial results and raised its FY24 revenue guidance above estimates.

CEL-SCI And U.S. FDA Approve Use Of PD-L1 Biomarker To Select Head And Neck Cancer Patients For Multikine Registration Study, Targeting Low PD-L1 Expression Patients With 5-Year Survival Rates Of 73%; Study Set To Begin Q1 2025

Liberty Formula One Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FWONA#NASDAQ">FWONA</a>) reported quarterly sales of $911.00 million which beat the analyst consensus estimate of $909.37 million by 0.18 percent. This is a 2.71 percent increase over sales of $887.00 million the same period last year.

Earnings Beats

FWONA

Liberty Formula One Group Q3 Sales $911.00M Beat $909.37M Estimate

Amid political challenges, Nippon Steel Corp.(OTC:<a class="ticker" href="https://www.benzinga.com/stock/NISTF#OTC">NISTF</a>) remains optimistic about finalizing its $14.1 billion acquisition of United States Steel Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/X#NYSE">X</a>) by the end of the year. The Japanese company is navigating opposition from unions and the Biden administration, while also facing potential hurdles from the recent election of Donald Trump, who plans to block the deal.
What Happened: Nippon Steel is determined to proceed with its acquisition of U.S. Steel, despite facing resistance from several fronts. The company argues that the deal will benefit the U.S. economy by creating jobs and enhancing competitiveness against China&#8217;s steel industry, Bloomberg <a href="https://www.bloomberg.com/news/articles/2024-11-07/nippon-steel-still-thinks-us-deal-can-be-completed-this-year">reported </a>on Thursday.
However, Trump&#8217;s election victory has introduced new complications, as he intends to block the acquisition in line with his anticipated isolationist policies. The United Steelworkers union also opposes the deal, citing concerns over job security for its members.
See Also: <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41763537/bitcoin-hits-71k-ethereum-dogecoin-surge-as-results-trickle-in-for-trump-harris-presidenti?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Bitcoin Hits $71K, Ethereum, Dogecoin Surge As Results Trickle In For Trump-Harris Presidential Battle: A</a>
Vice Chairman Takahiro Mori of Nippon Steel expressed optimism. "Now that the election is over, we believe that there can be constructive discussions about this deal," he said.
The company has received approval from the Committee on Foreign Investment in the United States to refile its bid, extending its timeline to finalize the acquisition. Nippon Steel has also committed to a $1.3 billion investment in U.S. Steel operations and plans to sell its stake in an Alabama mill to address antitrust concerns.
Why It Matters: The acquisition of U.S. Steel by Nippon Steel has been a topic of significant interest, especially following U.S. Steel&#8217;s <a href="https://www.benzinga.com/news/earnings/24/10/41665667/us-steel-reports-better-than-expected-q3-results-aims-to-close-nippon-steel-deal-by-year-end">better-than-expected third-quarter results</a>, which bolstered confidence in the deal&#8217;s completion by year-end. However, political opposition has been a major hurdle. 
In October, <a href="https://www.benzinga.com/markets/equities/24/10/41445066/as-trump-kamala-harris-and-biden-unite-against-nippon-steels-15b-us-steel-acquisition-japanese-s">Trump, Kamala Harris, and Biden</a> voiced against the acquisition, leading Nippon Steel to increase its lobbying efforts in Washington, spending $1.3 million between July and September. This acquisition is crucial for Nippon Steel&#8217;s strategy to expand its global footprint and compete with Chinese steelmakers, making the outcome of this deal significant for the international steel industry.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41794596/bitcoin-ethereum-dogecoin-slingshot-to-the-moon-after-trump-victory-but-sharp-correction-m?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Bitcoin, Ethereum, Dogecoin Slingshot To The Moon After Trump Victory But &#8216;Sharp&#8217; Correction Might Be In Store: Analyst Views BTC Between $80-90K By End Of Year</a></li>
</ul>
Disclaimer: This content was partially produced with the help of&nbsp;<a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a>&nbsp;and was reviewed and published by Benzinga editors
Image by Poetra.RH via Shutterstock

NISTF

Nippon Steel Remains Confident In $14B US Steel Deal Despite Trump's Resistance: 'There Can Be Constructive Discussions'

Helix Biopharma GAAP EPS of -$0.01

HBPCF

Helix BioPharma

Comments

Helix BioPharma

Notizie

Ultime notizie per Helix BioPharma (OTC:HBPCF) Azioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO